Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Assessing Quality of Life of Patients With Prostate Cancer Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on Assessing Quality of Life of Patients With Prostate Cancer conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Assessing Quality of Life of Patients With Prostate Cancer Clinical research trials and Assessing Quality of Life of Patients With Prostate Cancer healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including Assessing Quality of Life of Patients With Prostate Cancer. Assessing Quality of Life of Patients With Prostate Cancer Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Assessing Quality of Life of Patients With Prostate Cancer clinical trial. Test subjects oftentimes recieve the best healthcare possible for their Assessing Quality of Life of Patients With Prostate Cancer condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.

Home > "A" Clinical Trials Conditions > Assessing Quality of Life of Patients With Prostate Cancer

Assessing Quality of Life of Patients With Prostate Cancer



Assessing Quality of Life of Patients With Prostate Cancer

For Condition: Quality of Life,stage 1 prostate cancer,stage 2 prostate cancer,stage 3 prostate cancer,stage 4 prostate cancer
Status: Recruiting
Sponsor(s): EORTC Quality of Life Study Group , EORTC Genito-Urinary Tract Cancer Cooperative Group
Synopsis: RATIONALE: Quality of life assessment in patients undergoing prostate cancer treatment may help determine the intermediate and long-term effects of the treatment on these patients. PURPOSE: Clinical trial to study the effectiveness of two questionnaires in assessing quality of life of patients who have prostate cancer.
Details: OBJECTIVES: - Assess the scale structure, psychometric validity, and reliability of quality of life measurements using the EORTC QLQ-C30 and the prostate cancer-specific QLQ-PR25 questionnaires in patients with stage I-IV prostate cancer. OUTLINE: This is a multicenter study. Patients are stratified according to stage of disease (local or locally advanced disease vs metastatic disease). Patients complete EORTC QLQ-C30 and prostate cancer-specific QLQ-PR25 questionnaires before therapy and at 3 months after the start of therapy. Patients in stratum II also complete questionnaires at 6 months after the start of therapy. PROJECTED ACCRUAL: A total of 375 patients will be accrued for this study.
Eligibility:
Study Type:
  Interventional, Treatment
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: DISEASE CHARACTERISTICS: - Histologically confirmed prostate cancer - Stratum I: - Clinically localized primary prostate cancer - T1-T3, G1-G3, N0, M0 - Plan to undergo a radical prostatectomy OR - Local or locally advanced primary prostate cancer - T1-T4, G1-G3, N0, M0 - Plan to undergo radiotherapy with curative intent - Stratum II: - Metastatic prostate cancer - T1-T4, G1-G3, N1, M0-M1 OR - T1-T4, G1-G3, N0-1, M1 - Plan to receive hormonal treatment - No anti-androgen monotherapy - No cerebral metastases PATIENT CHARACTERISTICS: Age: - Any age Performance status: - Not specified Life expectancy: - Not specified Hematopoietic: - Not specified Hepatic: - Not specified Renal: - Not specified Other: - Mentally fit to complete a questionnaire - Literate in the language of the questionnaires - No psychological, familial, sociological, or geographical condition that would preclude compliance - No other concurrent malignancy except basal cell skin cancer - No concurrent participation in other quality of life investigations that would preclude study participation PRIOR CONCURRENT THERAPY: Biologic therapy: - Not specified Chemotherapy: - Not specified Endocrine therapy: - See Disease Characteristics - No prior neoadjuvant hormonal treatment - Planned adjuvant hormonal therapy (orchiectomy, luteinizing hormone-releasing hormone analogue, or maximal androgen blockade) is allowed for patients in stratum I Radiotherapy: - See Disease Characteristics - No interstitial radiotherapy - More than 2 years since prior radiotherapy (stratum II) Surgery: - See Disease Characteristics - More than 2 years since prior prostatectomy (stratum II) Other: - No prior treatment for prostate carcinoma
Total Enrollment: 

Location and Contact Information:

Overall Study Official:
GeorgeAndel,  ,  Onze Lieve Vrouwe Gasthuis

Onze Lieve Vrouwe Gasthuis *Recruiting*
Amsterdam,  ,  1091 HA
Netherlands
Recruiting Contact  Person 31-20-599-9111

Universitair Ziekenhuis Gent *Recruiting*
Ghent,  ,  B-9000
Belgium
Recruiting Contact  Person 32-92-240-2011

Rigshospitalet *Recruiting*
Copenhagen,  ,  2100
Denmark
Recruiting Contact  Person 45-3-545-4286

U.Z. Gasthuisberg *Recruiting*
Leuven,  ,  B-3000
Belgium
Recruiting Contact  Person 32-16-33-2211

Velindre Cancer Center at Velinde Hospital *Recruiting*
Cardiff,  Wales,  CF14 2TL
United Kingdom
Recruiting Contact  Person 44-29-2061-5888

Groot Ziekengasthuis 's-Hertogenbosch *Recruiting*
's-Hertogenbosch,  ,  5211 NL
Netherlands
Recruiting Contact  Person 31-73-611-2446

Marmara University Hospital *Recruiting*
Istanbul,  ,  81190
Turkey
Recruiting Contact  Person 90-212-327-5050

Academisch Medisch Centrum *Recruiting*
Amsterdam,  ,  1105 AZ
Netherlands
Recruiting Contact  Person 31-20-566-9111

Rijnstate Hospital *Recruiting*
ARNHEM,  ,  6800 TA
Netherlands
Recruiting Contact  Person 31-26-378-8888

Virga Jesse Hospital *Recruiting*
Hasselt,  ,  3500
Belgium
Recruiting Contact  Person 32-11-30-9990

Cazk Groeninghe - Campus Maria's Voorzienigheid *Recruiting*
Kortrijk,  ,  B-8500
Belgium
Recruiting Contact  Person 32-56-366-111

Spedali Civili *Recruiting*
Brescia,  ,  25124
Italy
Recruiting Contact  Person 39-3-995-483

University Hospital - Rotterdam Dijkzigt *Recruiting*
Rotterdam,  ,  3000 CA
Netherlands
Recruiting Contact  Person 31-10-463-9222

St. Elisabeth Ziekenhuis *Recruiting*
Tilburg,  ,  5022 GC
Netherlands
Recruiting Contact  Person 31-13-539-1313

Institute of Oncology - Bucarest *Recruiting*
Bucarest,  ,  RO 72435
Romania
Recruiting Contact  Person 40-1-240-8764

Sir Charles Gairdner Hospital - Perth *Recruiting*
Perth,  Western Australia,  6009
Australia
Recruiting Contact  Person 61-8-9346-3841

Hopital Jean Bernard *Recruiting*
Poitiers,  ,  86021
France
Recruiting Contact  Person 33-5-4944-4444

Universitaets-Krankenhaus Eppendorf *Recruiting*
Hamburg,  ,  D-20246
Germany
Recruiting Contact  Person 49-40-428-030

Ospedale S. Giovanni Battista *Recruiting*
Torino,  ,  10126
Italy
Recruiting Contact  Person 39-06-6566

Azienda Ospedaliera Maggiore Della Carita *Recruiting*
Novara,  ,  28100
Italy
Recruiting Contact  Person 39-321-373-3282

Academisch Ziekenhuis Groningen *Recruiting*
Groningen,  ,  9713 GZ
Netherlands
Recruiting Contact  Person 31-50-361-6161

Inselspital, Bern *Recruiting*
Bucarest,  ,  RO 72435
Romania
Recruiting Contact  Person 41-31-632-2111

Cliniques Universitaires Saint-Luc *Recruiting*
Brussels,  ,  1200
Belgium
Recruiting Contact  Person 32-2-764-1111

University of Wales College of Medicine *Recruiting*
Cardiff,  Wales,  CF14 4XN
United Kingdom
Recruiting Contact  Person 44-29-2074-7747

Daniel Den Hoed Cancer Center at Erasmus Medical Center *Recruiting*
Rotterdam,  ,  3008 AE
Netherlands
Recruiting Contact  Person 31-10-439-1911

University Medical Center Nijmegen *Recruiting*
Nijmegen,  ,  NL-6500 HB
Netherlands
Recruiting Contact  Person 31-24-361-1111

Universita di Palermo *Recruiting*
Palermo,  ,  90141
Italy
Recruiting Contact  Person 39-91-625-5292

Academisch Ziekenhuis der Vrije Universiteit Brussel *Recruiting*
Brussels,  ,  1090
Belgium
Recruiting Contact  Person 32-3-477-6040

Istituto Scientifico H.San Raffaele *Recruiting*
Milano,  ,  20132
Italy
Recruiting Contact  Person 39-2-643-2653

Universitaetsklinikum Bonn *Recruiting*
Bonn,  ,  D-53105
Germany
Recruiting Contact  Person 49-228-280-3816

Dokuz Eylul University School of Medicine *Recruiting*
Izmir,  ,  35340
Turkey
Recruiting Contact  Person 90-232-259-8773

Bristol Haematology and Oncology Centre *Recruiting*
Bristol,  England,  BS2 8ED
United Kingdom
Recruiting Contact  Person 44-117-923-0000

Norwegian Radium Hospital *Recruiting*
Oslo,  ,  N-0310
Norway
Recruiting Contact  Person 47-22-93-4000


Additional Information:
Study ID Numbers:
  CDR0000069463;  EORTC-30011,EORTC-15011
Study Start Date: 
Record last reviewed: July 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00041301

Other Stage 4 Prostate Cancer Studies:
1. Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia

2. Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

3. Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer

4. Survival TRaining for ENhancing Total Health (STRENGTH): Distance Medicine-Based Exercise and Diet in Preventing Body Composition Change in Patients Receiving Chemotherapy for Stage I, Stage II, or Stage IIIA Breast Cancer

5. ZD1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

Related Studies:

Other stage 4 prostate cancer Clinical Trials
Other Clinical Trials
Other Oslo Clinical Trials

Assessing Quality of Life of Patients With Prostate Cancer

Modify your Search

  Other stage 4 prostate cancer Clinical Trials
  Other Clinical Trials
  Other Oslo Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103